Literature DB >> 19234114

Hepcidin-induced internalization of ferroportin requires binding and cooperative interaction with Jak2.

Ivana De Domenico1, Eric Lo, Diane M Ward, Jerry Kaplan.   

Abstract

Hepcidin is a hormone secreted in response to iron loading and inflammation. Hepcidin binds to the iron exporter ferroportin, inducing its degradation and thus preventing iron entry into plasma. We determined that hepcidin binding to ferroportin leads to the binding and activation of the protein Janus Kinase2 (Jak2), which is required for phosphorylation of ferroportin. Ferroportin is a dimer and both monomers must be capable of binding hepcidin for Jak2 to bind to ferroportin. Once Jak2 is bound to the ferroportin dimer, both ferroportin monomers must be functionally competent to activate Jak2 and for ferroportin to be phosphorylated. These results show that cooperativity between the ferroportin monomers is required for hepcidin-mediated Jak2 activation and ferroportin down-regulation. These results provide a molecular explanation for the dominant inheritance of hepcidin resistant iron overload disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19234114      PMCID: PMC2656160          DOI: 10.1073/pnas.0900453106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Chemokine receptor dimerization: two are better than one.

Authors:  J M Rodríguez-Frade; M Mellado; C Martínez-A
Journal:  Trends Immunol       Date:  2001-11       Impact factor: 16.687

2.  Bradykinin B2 receptors activate Na+/H+ exchange in mIMCD-3 cells via Janus kinase 2 and Ca2+/calmodulin.

Authors:  Y V Mukhin; T Vlasova; A A Jaffa; G Collinsworth; J L Bell; B G Tholanikunnel; T Pettus; W Fitzgibbon; D W Ploth; J R Raymond; M N Garnovskaya
Journal:  J Biol Chem       Date:  2001-02-16       Impact factor: 5.157

3.  Involvement of JAK/STAT (Janus kinase/signal transducer and activator of transcription) in the thyrotropin signaling pathway.

Authors:  E S Park; H Kim; J M Suh; S J Park; S H You; H K Chung; K W Lee; O Y Kwon; B Y Cho; Y K Kim; H K Ro; J Chung; M Shong
Journal:  Mol Endocrinol       Date:  2000-05

Review 4.  Jaks and Stats in signaling by the cytokine receptor superfamily.

Authors:  J N Ihle; I M Kerr
Journal:  Trends Genet       Date:  1995-02       Impact factor: 11.639

5.  Janus kinase 2 (JAK2) regulates prolactin-mediated chloride transport in mouse mammary epithelial cells through tyrosine phosphorylation of Na+-K+-2Cl- cotransporter.

Authors:  N G Selvaraj; E Omi; G Gibori; M C Rao
Journal:  Mol Endocrinol       Date:  2000-12

6.  Mitogen-induced activation of Na+/H+ exchange in vascular smooth muscle cells involves janus kinase 2 and Ca2+/calmodulin.

Authors:  Maria N Garnovskaya; Yurii V Mukhin; Justin H Turner; Tamara M Vlasova; Michael E Ullian; John R Raymond
Journal:  Biochemistry       Date:  2003-06-17       Impact factor: 3.162

Review 7.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.

Authors:  J E Darnell; I M Kerr; G R Stark
Journal:  Science       Date:  1994-06-03       Impact factor: 47.728

8.  The hepcidin-binding site on ferroportin is evolutionarily conserved.

Authors:  Ivana De Domenico; Elizabeta Nemeth; Jenifer M Nelson; John D Phillips; Richard S Ajioka; Michael S Kay; James P Kushner; Tomas Ganz; Diane M Ward; Jerry Kaplan
Journal:  Cell Metab       Date:  2008-08       Impact factor: 27.287

9.  Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-gamma signal transduction pathway.

Authors:  D Watling; D Guschin; M Müller; O Silvennoinen; B A Witthuhn; F W Quelle; N C Rogers; C Schindler; G R Stark; J N Ihle
Journal:  Nature       Date:  1993-11-11       Impact factor: 49.962

10.  Induction of mutant dynamin specifically blocks endocytic coated vesicle formation.

Authors:  H Damke; T Baba; D E Warnock; S L Schmid
Journal:  J Cell Biol       Date:  1994-11       Impact factor: 10.539

View more
  58 in total

Review 1.  Diagnosis and management of iron deficiency anemia in patients with IBD.

Authors:  Jürgen Stein; Franz Hartmann; Axel U Dignass
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-10-05       Impact factor: 46.802

2.  Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in mice.

Authors:  Ivana De Domenico; Tian Y Zhang; Curry L Koening; Ryan W Branch; Nyall London; Eric Lo; Raymond A Daynes; James P Kushner; Dean Li; Diane M Ward; Jerry Kaplan
Journal:  J Clin Invest       Date:  2010-06-07       Impact factor: 14.808

3.  Multiple regulatory mechanisms act in concert to control ferroportin expression and heme iron recycling by macrophages.

Authors:  Carole Beaumont
Journal:  Haematologica       Date:  2010-08       Impact factor: 9.941

4.  Future alternative therapies for β-thalassemia.

Authors:  Stefano Rivella; Eliezer Rachmilewitz
Journal:  Expert Rev Hematol       Date:  2009-12-01       Impact factor: 2.929

Review 5.  Iron and immunity: immunological consequences of iron deficiency and overload.

Authors:  Bobby J Cherayil
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2010-09-28       Impact factor: 4.291

6.  The role of ubiquitination in hepcidin-independent and hepcidin-dependent degradation of ferroportin.

Authors:  Ivana De Domenico; Eric Lo; Baoli Yang; Tamara Korolnek; Iqbal Hamza; Diane McVey Ward; Jerry Kaplan
Journal:  Cell Metab       Date:  2011-10-20       Impact factor: 27.287

Review 7.  A systems biology approach to iron metabolism.

Authors:  Julia Chifman; Reinhard Laubenbacher; Suzy V Torti
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

Review 8.  Molecular mechanisms of normal iron homeostasis.

Authors:  An-Sheng Zhang; Caroline A Enns
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2009

9.  Iron Loading and Overloading due to Ineffective Erythropoiesis.

Authors:  Toshihiko Tanno; Jeffery L Miller
Journal:  Adv Hematol       Date:  2010-05-11

10.  Ferroportin and erythroid cells: an update.

Authors:  Luciano Cianetti; Marco Gabbianelli; Nadia Maria Sposi
Journal:  Adv Hematol       Date:  2010-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.